(P-1058) Characteristics and Real-world Outcomes of Patients Administered with Fecal Microbiota, live-jslm for the Prevention of Recurrent Clostridioides difficile Infection (rCDI)

Associate Professor of Medicine
Mayo Clinic
Rochester, MN, United States

Ferring Pharmaceuticals, Inc.
Parsippany, New Jersey, United States

Analysis Group, Inc.
Boston, Massachusetts, United States

Analysis Group
New York City, New York, United States

Analysis Group, Inc.
Boston, Massachusetts, United States

Analysis Group, Inc.
New York, New York, United States

Analysis Group, Inc.
New York, New York, United States

Senior Director, Health Outcome Research
Ferring Pharmaceuticals
parsippany, New Jersey, United States